|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/29 | |||
| A61P 1/16 | |||
| A61P 31/20 | |||
| A61K 35/16 |
| (11) | Patento numeris | 3148574 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15799654.7 |
| Europos patento paraiškos padavimo data | 2015-05-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/032807 |
| Data | 2015-05-28 |
| (87) | Numeris | WO 2015/184050 |
| Data | 2015-12-03 |
| (30) | Numeris | Data | Šalis |
| 201462003664 P | 2014-05-28 | US |
| (72) |
HOANG, Kieu, US
|
| (73) |
Rare Antibody Antigen Supply, Inc.,
30423 Canwood Street Suite 120, Agoura Hills, CA 91301,
US
|
| (54) | PURIFIED COMPOSITIONS OF IVIG AND KH PROTEINS FOR MODULATING LYMPHOCYTES AND TREATING HEPATITIS B VIRUS |
| PURIFIED COMPOSITIONS OF IVIG AND KH PROTEINS FOR MODULATING LYMPHOCYTES AND TREATING HEPATITIS B VIRUS |